Evidence map›Paper›PMID 34283971›Full record

ArticleImmunity2021

Pannexin 1 channels facilitate communication between T cells to restrict the severity of airway inflammation.

Christopher B Medina, Yu-Hsin Chiu, Marta E Stremska, Christopher D Lucas, Ivan Poon, Kenneth S Tung, Michael R Elliott, Bimal Desai, Ulrike M Lorenz, Douglas A Bayliss and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Immunity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 57 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Pannexins in the vasculature.American journal of physiology. Heart and circulatory physiology · 2025
    Review
  7. Review
  8. Pannexin channels in the kidney.American journal of physiology. Renal physiology · 2025
    Review
  9. Innate detection ofbioRxiv : the preprint server for biology · 2025
    Article
  10. The immunology of asthma.Nature immunology · 2025
    Review
  11. Article
  12. Article
  13. Pannexin channels in inflammation and tumorigenesis.Frontiers in cell and developmental biology · 2025
    Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. The ATP-exporting channel Pannexin-1 promotes CD8bioRxiv : the preprint server for biology · 2024
    Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 4 countries.

Christopher B MedinaCenter for Cell Clearance, University of Virginia, Charlottesville, VA 22908, USA; Departments of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA 22908, USA.
Yu-Hsin ChiuDepartment of Pharmacology, University of Virginia, Charlottesville, VA 22908, USA; Institute of Biotechnology and Department of Medical Science, National Tsing Hua University, Hsinchu, 30071, Taiwan.
Marta E StremskaDepartments of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA 22908, USA.
Christopher D LucasCenter for Cell Clearance, University of Virginia, Charlottesville, VA 22908, USA.
Ivan PoonDepartment of Biochemistry and Genetics, La Trobe University, Melbourne, VIC 3083, Australia.
Kenneth S TungDepartments of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA 22908, USA; Carter Immunology Center, University of Virginia, Charlottesville, VA 22908, USA.
Michael R ElliottCenter for Cell Clearance, University of Virginia, Charlottesville, VA 22908, USA; Departments of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA 22908, USA.
Bimal DesaiDepartment of Pharmacology, University of Virginia, Charlottesville, VA 22908, USA.
Ulrike M LorenzDepartments of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA 22908, USA; Carter Immunology Center, University of Virginia, Charlottesville, VA 22908, USA.
Douglas A BaylissDepartment of Pharmacology, University of Virginia, Charlottesville, VA 22908, USA.
Kodi S RavichandranCenter for Cell Clearance, University of Virginia, Charlottesville, VA 22908, USA; Departments of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA 22908, USA; Carter Immunology Center, University of Virginia, Charlottesville, VA 22908, USA; VIB/UGent Inflammation Research Centre and the Department of Biomedical Molecular Biology, Ghent University, 9000 Ghent, Belgium. Electronic address: ravi@virginia.edu.
University of Virginia · USCarter Center · USLa Trobe University · AU

Funding

Role of Pannexins in Vascular Smooth Muscle CellsP01HL120840 · NHLBI · UNIVERSITY OF VIRGINIA · PI BAYLISS, DOUGLAS A., RAVICHANDRAN, KODI S · 2014 to 2023
$24.0M
TRAINING IN THE PHARMACOLOGICAL SCIENCEST32GM007055 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI LYNCH, KEVIN R. · 1985 to 2022
$7.2M
TRPM7 at the Crossroads of Tissue Homeostasis and inflammationR01GM108989 · NIGMS · UNIVERSITY OF VIRGINIA · PI DESAI, BIMAL N. · 2016 to 2024
$3.3M
Mechanisms regulating apoptotic cell clearance in health and diseaseR35GM122542 · NIGMS · WASHINGTON UNIVERSITY · PI RAVICHANDRAN, KODI S · 2017 to 2021
$2.3M
Solute carrier proteins and metal ion-based signaling during efferocytosisR37AI159551 · NIAID · WASHINGTON UNIVERSITY · PI Kodi S Ravichandran · 2026 to 2026
$611k
Inducible and Reversible in vivo Protein Degradation (IRIP) - attempting a new approach for modulating immune responsesR21AI135455 · NIAID · UNIVERSITY OF VIRGINIA · PI LORENZ, ULRIKE · 2018 to 2019
$444k
Understanding T cell susceptibility to regulatory T cell-mediated suppressionR21AI139967 · NIAID · UNIVERSITY OF VIRGINIA · PI LORENZ, ULRIKE · 2019 to 2020
$435k
NHLBI NIH HHS P01 HL120840NIAID NIH HHS R21 AI135455NIAID NIH HHS R21 AI139967NIAID NIH HHS R37 AI159551NIGMS NIH HHS R01 GM108989NIGMS NIH HHS R35 GM122542NIGMS NIH HHS T32 GM007055Wellcome Trust 206566/Z/17/Z
6 · The paper itself

Abstract

Allergic airway inflammation is driven by type-2 CD4

Indexed as

AnimalsAsthmaCell CommunicationCell LineCell ProliferationConnexinsDisease Models, AnimalHEK293 CellsHumansJurkat CellsMiceMice, Inbred C57BLMice, KnockoutNerve Tissue ProteinsProtein Serine-Threonine KinasesRespiratory SystemConnexinsNerve Tissue ProteinsPanx1 protein, mouseProtein Serine-Threonine KinasesSik1 protein, mousePannexin 1, extracellular ATP, lung, asthma, airway inflammation, T regulatory cell, T effector cell, Salt-inducible kinase, CD4 T cell, adenosine

Identifiers

PMID34283971
PMCPMC8363584
OpenAlexW3186904131

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.